Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

2020632 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 21, Issue 4, pp. 571-580

Field-Weighted Citation Impact: 52.68